Global Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Region: Trend Forecast and Growth Opportunity

March 2022 | 194 pages | ID: G10FE716A17DEN
GMD Research

Abstracts

Global pharmaceutical contract research organization (CRO) market will reach $45.0 billion by 2030, growing by 9.8% annually over 2021-2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.

Highlighted with 118 tables and 80 figures, this 194-page report “Global Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire global pharmaceutical contract research organization (CRO) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2030 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global pharmaceutical contract research organization (CRO) market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Region.

Based on Service, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.

• CRO for Pre-clinical Development
• CRO for Phase I Trials
• CRO for Phase II Trials
• CRO for Phase III Trials
• CRO for Phase IV Trials
• Laboratory Services
• Consulting Services
• Data Management Services

Based on Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.

• Infectious Diseases
• Oncology
• Metabolic Disorders
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Gastrointestinal Disorders
• Other Therapeutic Applications

By End User, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.

• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, Other Nations)

For each aforementioned region and country, detailed analysis and data for annual revenue ($ bn) are available for 2021-2030. The breakdown of all regional markets by country and split of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

• Charles River Laboratories
• CMIC Co. Ltd
• Covance Inc.
• Hangzhou Tigermed Consulting Co., Ltd.
• ICON Plc
• IQVIA Holdings Inc.
• LSK Global Pharma Service Co., Ltd.
• Novotech Pty Ltd
• PAREXEL International Corporation
• Pharmaceutical Product Development LLC (PPD)
• PRA Health Sciences Inc.
• Quanticate Ltd
• Samsung Bioepis Co., Ltd.
• SGS SA (SGS Life Sciences)
• Syneos Health Inc.
• WuXi AppTec Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF GLOBAL MARKET BY SERVICE

3.1 Market Overview by Service
3.2 CRO for Pre-clinical Development
3.3 CRO for Phase I Trials
3.4 CRO for Phase II Trials
3.5 CRO for Phase III Trials
3.6 CRO for Phase IV Trials
3.7 Laboratory Services
3.8 Consulting Services
3.9 Data Management Services

4 SEGMENTATION OF GLOBAL MARKET BY THERAPEUTIC APPLICATION

4.1 Market Overview by Therapeutic Application
4.2 Infectious Diseases
4.3 Oncology
4.4 Metabolic Disorders
4.5 Cardiovascular Disorders
4.6 Central Nervous System
4.7 Respiratory Disorders
4.8 Gastrointestinal Disorders
4.9 Other Therapeutic Applications

5 SEGMENTATION OF GLOBAL MARKET BY END USER

5.1 Market Overview by End User
5.2 Pharmaceutical & Biopharmaceutical Companies
5.3 Medical Device Companies
5.4 Academic Institutes

6 SEGMENTATION OF GLOBAL MARKET BY REGION

6.1 Geographic Market Overview 2019-2030
6.2 North America Market 2019-2030 by Country
  6.2.1 Overview of North America Market
  6.2.2 U.S.
  6.2.3 Canada
  6.2.4 Mexico
6.3 European Market 2019-2030 by Country
  6.3.1 Overview of European Market
  6.3.2 Germany
  6.3.3 UK
  6.3.4 France
  6.3.5 Spain
  6.3.6 Italy
  6.3.7 Russia
  6.3.8 Rest of European Market
6.4 Asia-Pacific Market 2019-2030 by Country
  6.4.1 Overview of Asia-Pacific Market
  6.4.2 Japan
  6.4.3 China
  6.4.4 Australia
  6.4.5 India
  6.4.6 South Korea
  6.4.7 Rest of APAC Region
6.5 South America Market 2019-2030 by Country
  6.5.1 Argentina
  6.5.2 Brazil
  6.5.3 Chile
  6.5.4 Rest of South America Market
6.6 MEA Market 2019-2030 by Country
  6.6.1 UAE
  6.6.2 Saudi Arabia
  6.6.3 South Africa
  6.6.4 Other National Markets

7 COMPETITIVE LANDSCAPE

7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co., Ltd.
ICON Plc
IQVIA Holdings Inc.
LSK Global Pharma Service Co., Ltd.
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co., Ltd.
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc.

8 INVESTING IN GLOBAL MARKET: RISK ASSESSMENT AND MANAGEMENT

8.1 Risk Evaluation of Global Market
8.2 Critical Success Factors (CSFs)
Related Reports and Products

List Of Tables

LIST OF TABLES:

Table 1. Snapshot of Global Pharmaceutical CRO Market in Balanced Perspective, 2019-2030
Table 2. World Economic Outlook, 2021-2030
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn
Table 4. Worldwide Total Number of Registered Clinical Trials
Table 5. World Health Spending by Region, $ bn, 2013-2020
Table 6. Main Product Trends and Market Opportunities in Global Pharmaceutical CRO Market
Table 7. Global Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 8. Global Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 9. Global Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 10. Global Pharmaceutical CRO Market by Region, 2019-2030, $ bn
Table 11. Leading National Pharmaceutical CRO Market, 2021 and 2030, $ bn
Table 12. North America Pharmaceutical CRO Market by Country, 2019-2030, $ bn
Table 13. U.S. Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 14. U.S. Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 15. U.S. Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 16. Canada Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 17. Canada Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 18. Canada Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 19. Mexico Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 20. Mexico Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 21. Mexico Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 22. Europe Pharmaceutical CRO Market by Country, 2019-2030, $ bn
Table 23. Germany Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 24. Germany Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 25. Germany Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 26. UK Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 27. UK Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 28. UK Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 29. France Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 30. France Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 31. France Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 32. Spain Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 33. Spain Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 34. Spain Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 35. Italy Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 36. Italy Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 37. Italy Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 38. Russia Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 39. Russia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 40. Russia Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 41. Pharmaceutical CRO Market in Rest of Europe by Country, 2019-2030, $ bn
Table 42. APAC Pharmaceutical CRO Market by Country, 2019-2030, $ bn
Table 43. Japan Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 44. Japan Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 45. Japan Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 46. China Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 47. China Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 48. China Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 49. Australia Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 50. Australia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 51. Australia Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 52. India Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 53. India Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 54. India Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 55. South Korea Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 56. South Korea Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 57. South Korea Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 58. Pharmaceutical CRO Market in Rest of APAC by Country, 2019-2030, $ bn
Table 59. South America Pharmaceutical CRO Market by Country, 2019-2030, $ bn
Table 60. Argentina Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 61. Argentina Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 62. Argentina Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 63. Brazil Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 64. Brazil Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 65. Brazil Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 66. Chile Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 67. Chile Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 68. Chile Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 69. MEA Pharmaceutical CRO Market by Country, 2019-2030, $ bn
Table 70. UAE Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 71. UAE Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 72. UAE Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 73. Saudi Arabia Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 74. Saudi Arabia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 75. Saudi Arabia Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 76. South Africa Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 77. South Africa Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 78. South Africa Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 79. Breakdown of World Market by Key Vendor, 2020, %
Table 80. Charles River Laboratories: Company Snapshot
Table 81. Charles River Laboratories: Product Portfolio
Table 82. CMIC Co. Ltd.: Company Snapshot
Table 83. CMIC Co. Ltd.: Business Segmentation
Table 84. CMIC Co. Ltd.: Revenue by Region, 2018, %
Table 85. Covance Inc.: Company Snapshot
Table 86. Covance Inc.: Product Portfolio
Table 87. Covance Inc.: Revenue by Region, 2020, %
Table 88. Hangzhou Tigermed Consulting Co., Ltd.: Company Snapshot
Table 89. Hangzhou Tigermed Consulting Co., Ltd.: Business Segmentation
Table 90. ICON Plc: Company Snapshot
Table 91. ICON Plc: Business Segmentation
Table 92. ICON Plc: Product Portfolio
Table 93. ICON Plc: Revenue by Region, 2020, %
Table 94. IQVIA Holdings Inc.: Company Snapshot
Table 95. IQVIA Holdings Inc.: Business Segmentation
Table 96. IQVIA Holdings Inc.: Revenue by Region, 2020, %
Table 97. IQVIA Holdings Inc.: Product Portfolio
Table 98. LSK Global Pharma Service Co., Ltd.: Company Snapshot
Table 99. Novotech Pty Ltd: Company Snapshot
Table 100. PAREXEL International Corporation: Company Snapshot
Table 101. PAREXEL International Corporation: Business Segmentation
Table 102. PAREXEL International Corporation: Revenue by Region, 2018, %
Table 103. PAREXEL International Corporation: Product Portfolio
Table 104. Pharmaceutical Product Development LLC (PPD): Company Snapshot
Table 105. PRA Health Sciences Inc.: Company Snapshot
Table 106. PRA Health Sciences Inc.: Business Segmentation
Table 107. PRA Health Sciences Inc.: Revenue by Region, 2018, %
Table 108. Quanticate Ltd: Company Snapshot
Table 109. Samsung Bioepis Co., Ltd.: Company Snapshot
Table 110. SGS SA (SGS Life Sciences): Company Snapshot
Table 111. SGS SA (SGS Life Sciences): Business Segmentation
Table 112. SGS SA (SGS Life Sciences): Revenue by Region, 2018, %
Table 113. Syneos Health Inc.: Company Snapshot
Table 114. Syneos Health Inc.: Business Segmentation
Table 115. Syneos Health Inc.: Revenue by Region, 2018, %
Table 116. WuXi AppTec Inc.: Company Snapshot
Table 117. Risk Evaluation for Investing in Global Market, 2021-2030
Table 118. Critical Success Factors and Key Takeaways

List Of Figures

LIST OF FIGURES:

Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2030
Figure 5. Global Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Global Pharmaceutical CRO Market
Figure 8. Leading Causes of Death in the World, 2019-2020, million
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of Global Pharmaceutical CRO Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Fiver Forces Analysis of Global Pharmaceutical CRO Market
Figure 14. Breakdown of Global Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue
Figure 15. Global Addressable Market Cap in 2022-2030 by Service, Value ($ bn) and Share (%)
Figure 16. Global Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn
Figure 17. Global Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn
Figure 18. Global Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn
Figure 19. Global Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn
Figure 20. Global Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn
Figure 21. Global Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn
Figure 22. Global Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn
Figure 23. Global Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn
Figure 24. Breakdown of Global Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue
Figure 25. Global Addressable Market Cap in 2022-2030 by Therapeutic Application, Value ($ bn) and Share (%)
Figure 26. Global Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn
Figure 27. Global Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn
Figure 28. Global Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn
Figure 29. Global Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn
Figure 30. Global Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn
Figure 31. Global Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn
Figure 32. Global Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn
Figure 33. Global Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn
Figure 34. Breakdown of Global Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue
Figure 35. Global Addressable Market Cap in 2022-2030 by End User, Value ($ bn) and Share (%)
Figure 36. Global Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn
Figure 37. Global Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn
Figure 38. Global Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn
Figure 39. Global Market Snapshot by Region
Figure 40. Geographic Spread of Worldwide Pharmaceutical CRO Market, 2019-2030, % of Sales Revenue
Figure 41. Global Addressable Market Cap in 2022-2030 by Region, Value ($ bn) and Share (%)
Figure 42. North American Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 43. Breakdown of North America Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue
Figure 44. Contribution to North America 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 45. U.S. Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 46. Canada Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 47. Pharmaceutical CRO Market in Mexico, 2015-2030, $ bn
Figure 48. European Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 49. Breakdown of European Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue
Figure 50. Contribution to Europe 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 51. Pharmaceutical CRO Market in Germany, 2019-2030, $ bn
Figure 52. Pharmaceutical CRO Market in UK, 2019-2030, $ bn
Figure 53. Pharmaceutical CRO Market in France, 2019-2030, $ bn
Figure 54. Pharmaceutical CRO Market in Spain, 2019-2030, $ bn
Figure 55. Pharmaceutical CRO Market in Italy, 2019-2030, $ bn
Figure 56. Pharmaceutical CRO Market in Russia, 2019-2030, $ bn
Figure 57. Pharmaceutical CRO Market in Rest of Europe, 2019-2030, $ bn
Figure 58. Asia-Pacific Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 59. Breakdown of APAC Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue
Figure 60. Contribution to APAC 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 61. Pharmaceutical CRO Market in Japan, 2019-2030, $ bn
Figure 62. Pharmaceutical CRO Market in China, 2019-2030, $ bn
Figure 63. Pharmaceutical CRO Market in Australia, 2019-2030, $ bn
Figure 64. Pharmaceutical CRO Market in India, 2019-2030, $ bn
Figure 65. Pharmaceutical CRO Market in South Korea, 2019-2030, $ bn
Figure 66. Pharmaceutical CRO Market in Rest of APAC, 2019-2030, $ bn
Figure 67. South America Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 68. Breakdown of South America Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue
Figure 69. Contribution to South America 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 70. Pharmaceutical CRO Market in Argentina, 2019-2030, $ bn
Figure 71. Pharmaceutical CRO Market in Brazil, 2019-2030, $ bn
Figure 72. Pharmaceutical CRO Market in Chile, 2019-2030, $ bn
Figure 73. Pharmaceutical CRO Market in Rest of South America, 2019-2030, $ bn
Figure 74. Pharmaceutical CRO Market in MEA, 2019-2030, $ bn
Figure 75. Breakdown of MEA Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue
Figure 76. Contribution to MEA 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 77. Pharmaceutical CRO Market in UAE, 2019-2030, $ bn
Figure 78. Pharmaceutical CRO Market in Saudi Arabia, 2019-2030, $ bn
Figure 79. Pharmaceutical CRO Market in South Africa, 2019-2030, $ bn
Figure 80. Growth Stage of Global Pharmaceutical CRO Industry over the Forecast Period